A detailed history of Css LLC transactions in Organon & Co. stock. As of the latest transaction made, Css LLC holds 54,745 shares of OGN stock, worth $806,393. This represents 0.1% of its overall portfolio holdings.

Number of Shares
54,745
Previous 36,000 52.07%
Holding current value
$806,393
Previous $745,000 40.54%
% of portfolio
0.1%
Previous 0.07%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.65 - $23.03 $349,594 - $431,697
18,745 Added 52.07%
54,745 $1.05 Million
Q2 2024

Aug 14, 2024

BUY
$17.45 - $21.96 $209,400 - $263,520
12,000 Added 50.0%
36,000 $745,000
Q1 2024

May 15, 2024

BUY
$13.78 - $18.8 $55,120 - $75,200
4,000 Added 20.0%
24,000 $451,000
Q4 2023

Feb 14, 2024

SELL
$10.95 - $17.32 $98,550 - $155,880
-9,000 Reduced 31.03%
20,000 $288,000
Q3 2023

Nov 14, 2023

SELL
$16.59 - $23.77 $33,180 - $47,540
-2,000 Reduced 6.45%
29,000 $503,000
Q2 2023

Aug 14, 2023

BUY
$19.27 - $24.63 $385,400 - $492,600
20,000 Added 181.82%
31,000 $645,000
Q1 2023

May 15, 2023

SELL
$21.42 - $32.08 $171,360 - $256,640
-8,000 Reduced 42.11%
11,000 $258,000
Q4 2022

Feb 14, 2023

SELL
$23.31 - $28.61 $268,065 - $329,015
-11,500 Reduced 37.7%
19,000 $530,000
Q3 2022

Nov 14, 2022

BUY
$23.4 - $34.25 $409,500 - $599,375
17,500 Added 134.62%
30,500 $714,000
Q2 2022

Aug 15, 2022

BUY
$31.66 - $38.9 $411,580 - $505,700
13,000 New
13,000 $439,000
Q1 2022

May 16, 2022

SELL
$30.45 - $39.36 $384,888 - $497,510
-12,640 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$28.45 - $38.0 $359,608 - $480,320
12,640 New
12,640 $383,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.